KYGEVVI 2 g/2 g powder for oral solution

Licence holder

UCB Pharma S.A. (all products →)

Active substances

Doxecitine, Doxribtimine

Dosage form

Powder for oral solution

Route of administration

Oral use

ATC code

A16AX29

First authorised

26/03/2026

Prescription status

Product subject to prescription which may not be renewed (A)

Supply

Supply through pharmacies only

Legal basis

Full application (Article 8(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.